| Sector |
Healthcare
|
Compare with Sector peers |
| Industry |
Pharmaceuticals & Drugs
|
Compare with Industry peers |
| Website | http://www.denischemlab.com | |
| Market Cap | 204.20 Cr. | |
| Enterprise Value(EV) | 179.84 Cr. | 2023-09 |
| Financial Indicators | ||
|---|---|---|
| Earnings per share (EPS) | 6.63 | Trailing Twelve Months Ending 2023-12 |
| Price-Earning Ratio (PE) | 22.20 | Trailing Twelve Months Ending 2023-12 |
| Industry PE | 40.96 | Trailing Twelve Months Ending 2023-12 |
| Book Value / Share | 56.23 | Trailing Twelve Months Ending 2023-12 |
| Price to Book Value | 2.62 | Calculated using Price: 147.15 |
| Dividend Yield | 1.36 | Period Ending 2023-03 |
| No. of Shares Subscribed | 1.39 Cr. | 13,876,668 Shares |
| FaceValue | 10 | |
| About Denis Chem Lab Ltd. | ||
| The company is engaged in the business of manufacturing of Pharmaceuticals Transfusion Solution in Bottles. It offers wide range of sterile intravenous injectables for human and veterinary consumption. The company's product offerings comprise of various products sold across several states in India. It also exports sterile intravenous medicines to countries like Sri Lanka, Nepal, Combodia, Vietnam, Somalia, Ivory Cost etc. In addition to manufacturing its own products which it sells under its own brands, it does manufacture products on contract basis for third parties including certain multinational pharmaceutical companies who market such products under their own brands. | ||
| 1 Day |
|
+4.99% |
| 1 Week |
|
-10.23% |
| 1 Month |
|
+19.03% |
| 3 Month |
|
+12.94% |
| 6 Month |
|
+45.28% |
| 1 Year |
|
+107.19% |
| 2 Year |
|
+99.48% |
| 5 Year |
|
+108.78% |
| 10 Year |
|
+458.57% |
| 9 years | 2015-03 | 2016-03 | 2017-03 | 2018-03 | 2019-03 | 2020-03 | 2021-03 | 2022-03 | 2023-03 | |
| Return on Equity (%) | 0.62 | -30.41 | 5.86 | 5.37 | 11.94 | 7.29 | 3.76 | 9.79 | 11.33 | |
| Return on Capital Employed (%) | 10.93 | 5.3 | 12.19 | 9.37 | 11.9 | 11.34 | 6.5 | 13.79 | 16.07 | |
| Return on Assets (%) | 0.12 | -5.36 | 1.38 | 2.2 | 6.15 | 4.15 | 2.39 | 6.64 | 8.03 |
| Particulars | 10 years | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-09* Rs. Cr. |
| Shh. Funds | 17 | 16 | 30 | 50 | 56 | 59 | 62 | 66 | 72 | 75 | |
| Non Curr. Liab. | 25 | 22 | 20 | 11 | 6 | 4 | 6 | 5 | 3 | 2 | |
| Curr. Liab. | 39 | 46 | 44 | 40 | 43 | 34 | 25 | 25 | 24 | 34 | |
| Minority Int. | |||||||||||
| Equity & Liab. | 81 | 85 | 94 | 101 | 106 | 97 | 92 | 96 | 99 | 111 | |
| Non Curr. Assets | 44 | 51 | 46 | 48 | 51 | 47 | 44 | 43 | 40 | 39 | |
| Curr. Assets | 37 | 34 | 48 | 53 | 54 | 50 | 49 | 53 | 59 | 71 | |
| Misc. Exp. not W/O | |||||||||||
| Total Assets | 81 | 85 | 94 | 101 | 106 | 97 | 92 | 96 | 99 | 111 |
| Particulars | 10 years | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-12 Rs. Cr. TTM |
| Net Sales | 77 | 100 | 113 | 107 | 124 | 136 | 109 | 137 | 161 | 168 | |
| Other Income | 0 | 0 | 1 | 1 | 2 | 0 | 0 | 1 | 1 | 1 | |
| Total Income | 77 | 100 | 114 | 108 | 126 | 136 | 110 | 138 | 161 | 169 | |
| Total Expenditure | -68 | -91 | -99 | -95 | -110 | -121 | -99 | -122 | -142 | -147 | |
| PBIDT | 10 | 9 | 15 | 13 | 16 | 15 | 11 | 15 | 19 | 22 | |
| Interest | -5 | -7 | -6 | -5 | -3 | -3 | -2 | -1 | -1 | -1 | |
| Depreciation | -4 | -6 | -7 | -6 | -6 | -7 | -6 | -6 | -8 | -9 | |
| Taxation | 0 | -1 | -1 | 0 | 0 | -2 | -1 | -3 | -3 | -3 | |
| Exceptional Items | |||||||||||
| PAT | 0 | -4 | 1 | 2 | 6 | 4 | 2 | 6 | 8 | 9 | |
| Adjusted EPS | 0 | -5 | 1 | 2 | 5 | 3 | 2 | 5 | 6 | 7 |
| Particulars | 10 years | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. |
| Cash Fr. Operatn. | -2 | 14 | 21 | 7 | 11 | 8 | 13 | 8 | 17 | 16 | |
| Cash Fr. Inv. | -9 | -28 | -13 | -1 | -16 | -2 | -2 | -1 | -10 | -11 | |
| Cash Fr. Finan. | 12 | 13 | -7 | 0 | 1 | -5 | -14 | -6 | -7 | -4 | |
| Net Change | 0 | -1 | 1 | 5 | -4 | 1 | -3 | 1 | 0 | 1 | |
| Cash & Cash Eqvt | 3 | 2 | 3 | 6 | 2 | 3 | 0 | 2 | 1 | 2 |
|
Fri, 12 Apr 2024
Compliances-Compliances Certificate For The Period Ended 31St March 2024 We are hereby submitting Compliances Certificate under Reg 7(2) of Listing Regulations for the Financial Year ended 31st March 2024. |
|
Fri, 12 Apr 2024
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 Pursuant to Reg. 74(5) of SEBI(DP) Reg 2018 we are hereby submitting certificate issued by Link Intime India Private Limited Registrar and Share Transfer Agent of the company for the Quarter ended 31st March 2024 |
|
Fri, 12 Apr 2024
PCS Certificate In Terms Of Reg. 40(9) Of SEBI(LODR) Regulations 2015 For The Financial Year Ended On 31StMarch 2024. We are enclosing herewith PCS Certificate in terms of Reg. 40 of SEBI Listing Regulations. |
| Mon, 15 Apr 2024 |
Closing Below Previous Low
|
Closing Below Previous Low for 3 days
|
Making Lower Lows for 3 days
|
Closing Below Previous Low for 2 Days
|
Making Lower Lows for 2 Days
|
